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Abstract 
Obesity is linked to increased intestinal permeability that may contribute to low grade 
inflammation. Fructan prebiotics have been demonstrated to increase intestinal resistance and 
decrease systemic inflammation. The objective of this study was to test the effects of prebiotics 
on intestinal permeability, morphology, and gene expression in an obese mouse model. Obese, 
18-wk old, C57BL/6 mice were randomized to high-fat (45% of kcal) diets containing 5% 
cellulose, 10% cellulose, 10% short-chain fructooligosaccharides (scFOS) or 10% inulin and fed 
for 28 d. Distal ileum, cecum, and colon samples were collected for Ussing chamber, 
histomorphology, and qRT-PCR analyses. The effects of treatment were tested using the Mixed 
Models procedure of SAS. Among treatments, mice fed scFOS and inulin had greater (p<0.05) 
intestinal transmural resistance compared to mice fed 5% cellulose. MCT-1 expression was 
greater (p<0.05) in the distal colon of mice fed 10% cellulose compared to 10% inulin. ZO-1 
expression was lower (p<0.05) in mice fed inulin compared to other treatments. Occludin mRNA 
abundance was lowest (p<0.05) in fructan sources compared to cellulose. When comparing 5% 
vs. 10% cellulose treatments using contrasts, 10% cellulose led to greater (p<0.05) intestinal 
crypt depth in all intestinal regions, except the distal colon.  Mice fed 5% vs. 10% cellulose, 
however, had greater (p<0.05) ileal villus height: crypt depth ratio, ileal MUC2 mRNA 
abundance, proximal colon AMPK mRNA abundance, and occludin mRNA abundance in the 
proximal and distal colon regions. When comparing fructan vs. cellulose treatments using 
contrasts, fructans resulted in a greater (p<0.05) transmural resistance and crypt depth when all 
intestinal regions were combined.  In contrast, fructan-fed mice had lower (p<0.05) mRNA 
abundance of ZO-1 and occludin when all intestinal regions were combined (Table 3.5). Fructan 
consumption resulted in lower (p<0.05) ileal MUC2 and occludin mRNA abundance, cecal 
occludin mRNA abundance, proximal colon MCT-1, ZO-1, AMPK, and occludin mRNA 
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abundance, and distal colon ZO-1, AMPK, and occludin mRNA abundance.  Cecal AMPK 
mRNA abundance was greater (p<0.05) in fructan-fed compared to cellulose-fed mice.  Pearson 
coefficient correlations indicated correlations between MCT-1 and distal colon ZO-1 (r = 0.77, 
p<0.05) and occludin mRNA abundance (r = 0.66, p<0.05). AMPK correlated with ZO-1 mRNA 
abundance (r = > 0.60, p<0.05) in all regions of the intestinal tissue of C57BL/6 mice. Lastly, 
ZO-1 mRNA abundance correlated with distal colon epithelial resistance (r = 0.51, p<0.05). 
Collectively, these data may suggest mechanisms by which equivalent quantities of fructan 
prebiotics and non-fermentable fibers affect intestinal barrier function.  
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Chapter 1 
  Introduction 
According to the Centers for Disease Control and Prevention (CDC), in 2008, 34.4% of 
U.S. adults were overweight and 33.9% were obese. Furthermore, not one state in the U.S. had 
less than 15% of obese adults (which was the Healthy People 2010 objective). The epidemic of 
obesity has plagued many Americans with co-morbidities such as hypertension, cardiovascular 
diseases, and type-2 diabetes. This condition is not only a detriment to quality of life, but also 
causes financial hardship. In 2008, those that were obese experienced $1,429 more in medical 
expenses than normal weight individuals due to obesity-induced co-morbidities (CDC Vital 
Signs, 2010). In addition, researchers found that obesity is also the predominant etiology of 
metabolic dysfunctions (Cani & Delzenne, 2009). Not only has excessive weight accumulated in 
the form of adipose tissue been shown to cause insulin resistance, hyperlipidemia, and low-grade 
inflammation, but also has been shown to change the intestinal microbiota negatively. Intestinal 
bacteria work symbiotically with the host to provide nutrients and promote gut health; however, 
a change in intestinal bacterial communities has been shown to cause declines in gut health, 
including increasing gut inflammation and intestinal barrier function deterioration. In an obese 
state, researchers have observed an increased colonization of Firmicutes and a decline in 
Bacteriodetes (Ley et al., 2006). This change in intestinal bacteria has not yet been linked to gut 
inflammation and intestinal barrier decline; however, it has been theorized that alterations in 
intestinal bacteria play a major role in the decline of gut health in an obese individual.  
Maintenance of intestinal barrier function has been of great interest lately. The role of the 
intestinal barrier is highly significant and cannot be overlooked. In essence, it is the first line of 
defense against ingested noxious agents and hinders intestinal bacteria from entering systemic 
circulation, therefore preventing the fatal condition of sepsis (Groschwitz and Hogan, 2009).  
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In obese mouse models, this barrier has been compromised. Cani et al. (2009) reported 
decreased intestinal resistance in the jejunum of obese mice, which was associated with a change 
in intestinal bacteria and increased levels of systemic inflammation. That study also tested the 
effects of fructan prebiotics, which decreased systemic inflammation markers and intestinal 
barrier permeability. These indigestible carbohydrates, known as prebiotics, selectively stimulate 
beneficial bacteria in the gut of the host and have been shown to overcome the metabolic distress 
of obesity and produce a healthy microbiota in addition to restoring intestinal barrier function in 
the obese (Gibson and Roberfroid, 1995; Cani et al., 2009; Roberfroid et al., 2010). Fermentation 
of prebiotics not only lowers intra-luminal pH that decreases pathogen colonization within the 
gut and increases production of short-chain fatty acids, such as butyrate, which is the preferred 
energy source for colonocytes, but also has been found to decrease intestinal barrier permeability 
in obese mouse models.   
The general objective of this research was to identify mechanisms by which the integrity 
of the intestinal architecture and barrier are improved via supplementation of prebiotics with 
varying fermentation characteristics in an obese mouse model.  
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Chapter 2 
Literature review 
Intestinal barrier function 
The selective permeability of the intestinal barrier is an important component of 
gastrointestinal function. It not only is comprised of a single-cellular epithelial layer that is 
conjoined by the primary supports of tight junction (TJ) adhesions, but also consists of a mucus 
layer and associated immune cells (Groschwitz and Hogan, 2009; Rescigno, 2011). However, the 
physical restrictions applied by the TJ (lateral spacing between epithelial cells) may warrant the 
greatest attention in maintaining the integrity of the barrier and the health of the host. The TJ 
functions to prevent the paracellular transport of intraluminal toxins, intestinal microflora, and 
foreign antigens from invading the lamina propria, portal circulation, and, eventually the 
systemic circulation. Paracellular transport is the passive diffusion of substrates through the 
intercellular space between adjacent epithelial cells. Tight junction proteins regulate the 
permeability of the paracellular space at the lateral membrane of each epithelial cell (Groschwitz 
and Hogan, 2009). Intestinal barrier regulation is accomplished through TJ protein-protein 
interactions and intracellular anchoring of TJ proteins to the actin cytoskeleton of the intestinal 
cells (Groschwitz and Hogan, 2009).  
There are three main TJ membrane proteins involved in the maintenance of the intestinal 
barrier: claudins, occludins, and zonula occludens (ZO). Junctional adhesion membrane (JAM) 
proteins have been less studied, but are also important in the maintenance of the intestinal 
barrier. Claudins contain hydrophobic transmembrane domains anchored by ZO intracellularly, 
and contain hydrophilic extracellular loops, that extend into the paracellular space (Van Itallie 
and Anderson, 2006). These loops are vital in the formation of ion-selective channels within the 
TJ complex. Furuse et al. (2002) demonstrated the importance of claudins, with the claudin-1 
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mutation (claudin-1 knockout mice) being fatal due to substantial transepidermal water loss. 
Occludin functions by interacting with ZO to adhere itself to the actin cytoskeleton of each 
epithelial cell (Furuse et al., 1994; Mitic et al., 2000). The hydrophilic domains of the occludin 
protein extend into the paracellular pathway to aid in selective transport. ZO-1, -2, and -3 form 
dense protein structures, known as cytoplasmic plaques in conjunction with other TJ adhesions 
(Groschwitz and Hogan, 2009). The interaction of ZO adhesions with JAM proteins is vital to 
the function of the TJ and cell-to-cell border. The crucial role of ZO proteins has been shown in 
ZO-1-deficient and ZO-2-deficient mouse embryos, which contained apoptic or necrotic cells in 
the notochord and neural tube, decreased angiogenesis due to vascular defects, and increased 
permeability in the apical junctions of embryonic cells. These finding were consistent with arrest 
of the embryos in early gastrulation (Katsuno et al., 2008; Xu et al., 2008). Laukoetter et al. 
(2007) reported that disruptions in siRNA-mediated knockdowns of JAM-A proteins in human 
SK-C015 colonic monolayers reduced (P<0.05) transepithelial resistance (TER) by 60% 
compared to controls. Furthermore, these researchers reported that JAM-A knockout mice 
suffered from increased dextran permeability, which was consistent with reduced TER, enhanced 
mucosal permeability and increased susceptibility to colitis, further indicating the importance of 
JAM proteins as structural adhesions in the intestinal barrier (Laukoetter et al., 2007). 
Researchers also have reported an extended role of ZO TJ proteins. Itoh et al. (1999) reported 
increased localization of ZO-1, -2, and -3 proteins at the TJ of intestinal epithelial cells in 
occludin- deficient mice. Immunoblotting procedures identified the interaction of ZO-1, -2, and -
3 bound to the C-terminus of claudin TJ proteins of these mice, which may indicate increased 
expression of ZO adhesions in order to maintain homeostasis of the epithelial barrier (Itoh et al., 
1999).  
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The contributions of each TJ protein serve an extraordinary function in preventing a 
leaky intestinal barrier. Maintaining the epithelial barrier decreases the host’s risk of bacteremia, 
endotoxemia [high levels of translocated bacterial lipopolysaccharides (LPS) from the gut to 
systemic circulation], and the uptake of intraluminal toxins and other osmotic contents into the 
systemic circulation. Therefore, the regulation of the intestinal barrier function is extremely 
important for health.  
Intestinal barrier dysfunction and its consequences  
There are conditions that can cause detrimental alterations to the barrier by inducing 
rearrangement and deterioration of the proteins composing the TJ complex, leading to intestinal 
and metabolic complications. A reduced epithelial barrier has been shown in several disease 
states, such as inflammatory bowel disease (IBD), sepsis, metabolic syndrome, and allergic 
responses, such as celiac disease. The symptoms of these diseases suggest intestinal barrier 
deterioration and associated consequences of dysbiosis, the mechanisms of which are discussed 
below.  
The disruption of the intestinal barrier can involve the TJ and the distortion of the cellular 
components of the barrier as well, including epithelial cell hypertrophy and apoptosis and villus 
atrophy (Song et al., 2009; John et al., 2011). Disruption of the epithelial barrier increases 
intestinal permeability and can yield explicit symptoms of osmotic diarrhea through paracellular 
and transcellular transport of solutes into the intestinal lumen, as seen in IBD patients [inclusive 
of ulcerative colitis (UC) and Crohn’s disease (CD)], with mild to severe intestinal inflammation. 
Mild ileocolonic inflammation, as generated in a TNF
(+/∆ARE)
 rodent model, which displays 
chronic to mild ileocolitis due to over-expression of TNF-α, was reported to result in decreased 
epithelial bicarbonate secretion and depression of fluid absorption within the ileum; these 
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findings were attributed to intestinal barrier breakdown (Xiao et al., 2011). It is speculated that 
the loss of gut barrier function is involved in the pathogenesis of multiple organ dysfunction 
syndrome (MODS) (Ammori et al., 1999; Velasco, 2006). Such patients were found to have high 
serum diamine oxidase (DAO) concentrations, which are released by damaged mucosal epithelial 
cells, endotoxemia, and a pronounced reduction in TER, all of which correlate strongly with 
intestinal barrier dysfunction (Zhang et al., 2010). MODS patients who underwent continuous 
venovenous hemofiltration for 24 h had a reduction (p<0.05) in serum DAO and increased 
(p<0.05) TER compared to 0 h. Gut barrier loss was attributed to downregulation and 
reorganization of TJ adhesions. Specifically, intestinal occludin and ZO-1 protein levels were 
50% lower (p<0.01) in MODS patients compared to healthy controls (Zhang et al., 2010).  
Intestinal bacteria appear to have an important role in the pathogenesis of intestinal 
barrier dysfunction. A correlation between intestinal barrier decline and specific microbiota has 
yet to be discovered. However, certain microbial species have been linked to IBD and it is 
known that during active IBD, intestinal architectural and TJ complexes undergo structural 
changes. Frank et al. (2007) reported that small bowel mucosal biopsies of IBD patients had 
decreased (p<0.001) populations of Lachnospiraceae (subgroup of Firmicutes) by more than 
300-fold and Bacteroidetes by 50-fold and increased (p<0.001) Proteobacteria and Bacillus 
(subgroup of Firmicutes) compared to non-IBD patients. Frank et al. (2011) did not report a 
difference in Enterobacteriaceae (phyla Proteobacteria) populations in IBD patients vs. 
controls, yet Kotlowski et al. (2007) reported that E. coli (family Enterobacteriaceae) were 3 to 
4 log units greater (p<0.05) in IBD patients with increased (p=0.04) pathogenic B2+D 
phylogenetic groups of E. coli (E. coli phylogenic groups B2 and D are virulent groups) 
compared to controls. E. coli is classified as a gram-negative bacterium and has been implicated 
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in endotoxemia (Raetz and Whitfield, 2002). Bloom et al. (2011) also reported the involvement 
of specific commensal bacteria in the development of IBD. Bacterial members of the genus 
Bacteroides, specifically Bacteroides vulgates and Bacteroides thetaiotaomicron, were reported 
to cause severe UC in conventionalized germ-free dnKO mice (mice contain defects in IL-10 and 
TGFβ anti-inflammatory pathways) (Bloom et al., 2011). This study also reported that the 
presence of Firmicutes (families including Lactobacillaceae, Bacillaceae and Lachnospriaceae) 
did not generate colitis in conventionalized germ-free dnKO mice. Zeissig et al. (2007) used 
freeze fracture electron microscopy to report a decline (p<0.001) in TJ adhesions (4.7 TJ strands 
per 1000 nm single-strand length) at the surface of the sigmoid colon during active CD compared 
to healthy controls (7.2 TJ strands per 1000 nm single-strand length) and reduced (p<0.001) TJ 
adhesions within the crypt compared to controls (4.4 TJ strands and 7 TJ strands per 1000 nm 
single-strand length, respectively). Furthermore, these researchers reported decreased (p<0.01) 
transmural impedance among active CD patients (23 Ω*cm2 compared to 39 Ω*cm2 in controls). 
Proinflammatory mediators, TNF-α and IFN-γ, which are associated with LPS-mediated 
cytokine release, have been found to deteriorate TJ architecture by decreasing claudin expression 
and ZO-1 redistribution in IBD patients (Zeissig et al., 2007; Capaldo and Nusrat, 2009). 
Collectively, these findings suggest a sequence of events leading to declining intestinal barrier 
function. Disruption of the intestinal barrier is associated with endotoxemia in IBD patients. 
Approximately 88% of UC patients and 94% of CD patients have been reported to have systemic 
endotoxemia (Gardiner et al., 1995; Zeissig et al., 2007). Endotoxemia causes an uncontrolled 
immunological response leading to secretion of proinflammatory cytokines, organ dysfunction, 
growth failure in children, and in 60% of severe sepsis patients, death (Pasternak et al., 2010; 
Krzystek-Korpacka et al., 2011).  
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The endotoxin, LPS, is found within the cell wall of gram-negative bacteria, such as E. 
coli. For every E. coli cell present within the human gut, there is 10
6
 lipid A residues (~80% of 
the bacterial cell wall), which is the active endotoxin component of LPS (Raetz and Whitfield, 
2002; Taniguchi et al., 2009; Laugerette et al., 2010). It is pertinent to note that within the 
gastrointestinal tract of a healthy human, there is 0.1 mg of LPS present, which may not cause 
any harm to the host; however, this value varies based on one’s diet, weight, lifestyle, and overall 
health (Raetz and Whitfield, 2002; Taniguchi et al., 2009). Lipopolysaccharides elicit a 
proinflammatory immunological response via pattern-recognition receptors called toll-like 
receptors (TLR), that are found on macrophages, dendritic cells, intestinal epithelial cells, and 
other antigen-presenting cells (Taniguchi et al., 2009; Khoo et al., 2011).  
Another primary factor thought to lead to increased intestinal barrier permeability is diet. 
High consumption of alcohol and dietary fats, such as palmitic acid (C16:0) and oleic acid 
(C18:1), have been evaluated for their effects on the integrity of the intestinal barrier. 
Researchers have shown that increased alcohol intake can reduce intestinal barrier function 
through downregulation and reorganization of TJ adhesions. Zhong et al. (2010) reported that a 
daily intake of ethanol at 38% of total caloric intake by C57BL/6 mice decreased apical-lateral 
dispersal of ileal ZO-1 and occludin at the TJ complex. In congruence with TJ function, it was 
also reported that the absorption of FITC-dextran with a molecular weight of 4,000 (FD-4) 
within the ileum was higher (p<0.05) in alcohol-fed mice (~3 µg/cm/min) compared to controls 
(1 µg/cm/min). This increased ileal permeability also was associated with elevated (p<0.05) 
plasma LPS concentrations in the alcohol-fed mice (0.5 EU/ml) compared to controls (0.2 
EU/ml), which suggests that high alcohol consumption causes the disarray of TJ adhesions, 
increased intestinal permeability, and leakage of bacterial endotoxins into systemic circulation 
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(Zhong et al., 2010). Excessive alcohol intake is also thought to cause an overgrowth of gram-
negative bacteria and LPS flux in the gut, possibly contributing to these changes.  
Excessive caloric intake in the form of dietary lipids was evaluated by Suzuki and Hara 
(2010) in lean Long Evans Tokushima Otsuka (LETO) and obese Otsuka Long Evans 
Tokushima Fatty (OLETF) rats. The results of this study concluded that intestinal permeability 
measured via Cr-EDTA excretion in urine was higher (p<0.01) in LETO and OLETF rats 
consuming a high-fat diet (average 4.5% urinary Cr-EDTA, 300 g/kg; 7% soybean oil, 23% lard) 
compared to a standard diet (average 2.85% urinary Cr-EDTA, 70 g/kg; soybean oil only). In the 
small intestinal mucosa cell fractionations of both OLETF and LETO rats consuming a high-fat 
diet vs. standard fed rats, a reduced expression of TJ proteins, shown as the area under the curve 
(AU) was found, such as claudin-1 (average 0.475 AU vs. 1.25 AU), claudin-3 (average 1.02 AU 
vs. 1.5 AU) and JAM-1 (average 0.9 AU vs. 1.1 AU) (Suzuki and Hara, 2010). Furthermore, 
plasma TNF-α concentrations were 3 times higher (p<0.05) in the OLETF rats consuming a 
high-fat diet compared to OLETF rats consuming the standard chow diet and LETO rats fed the 
high-fat or standard chow diets. It is well documented that high-fat diets stimulate TLR4 
receptors in a similar manner as lipid-containing bacterial endotoxins. Suganami et al. (2007) 
reported that TLR4 knockout murine peritoneal macrophages treated with palmitate attenuated 
(p<0.01) TNF-α mRNA expression. Furthermore, DNA microarray analysis of RAW264 
macrophages (murine macrophage cell lines) incubated with palmitate or LPS showed up-
regulation of TNF-α and genes in the NF-κB pathway, such as NF-κB1 (p50) and RelA (p65); 
therefore, the conclusion was made that palmitate and LPS use the NF-κB pathway as a common 
pathway for cytokine secretion (Suganami et al., 2007). Cytokine release, in turn, can lead to 
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disorganization of the TJ proteins at the apical-lateral membrane causing increased intestinal 
permeability (Adams et al., 1993; Shi et al., 2006).  
In addition to studying total dietary fat concentrations in inflammatory processes, others 
have assessed the involvement of specific fatty acids. The lipid composition of animal fats, 
which are thought to be associated with inflammatory processes, consist of 26.6% palmitic acid 
and 43.1% oleic acid (Zhao et al., 2005). Rockett et al. (2010) reported that incubation of B cells 
with 50 mM of palmitate for 48 h increased (p<0.05) apoptosis by 3-fold compared to a BSA 
control. Aspenstrom-Fagerlund et al. (2007) demonstrated that Caco-2 cells exposed to 15 or 30 
mM of oleic acid between 30 to 90 min caused cytotoxicity [as measured by apical leakage of 
lactate dehydrogenase (LDH)], increased (p<0.05) 
12
C-mannitol absorption (~ 2% absorption), 
which measures paracellular permeability, and decreased (p<0.05) transepithelial electrical 
resistance (TEER) compared to controls (0% absorption of 12C-mannitol and 117% relative 
TEER, respectively); 5 mM of oleic acid exposure from 30 to 90 min, however, had no effect on 
the absorption of 
12
C-mannitol in these monolayers, indicating the deterioration of the barrier in 
a dose-and time-dependent manner. These reports suggest that the dietary fatty acids ingested are 
significant in regulating the expression of TJ proteins and influencing intestinal permeability, 
possibly through cytokine-mediated processes (Rockett et al., 2010). Further assessment of the 
fatty acid composition has shown that increased intake of omega-6 (n-6) fatty acid composition 
sources (e.g., animal fats, meats, and corn oil), commonly found in the Western diet, leads to the 
generation of prostaglandins PGE2, PGI2, and TXA2 derived from arachidonic acid (AA), which 
employs a proinflammatory effect (Russo, 2009). Therefore, an imbalance of n-6:n-3 of 20:1, 
which is commonly found in the Western diet, has been implicated in the generation of such 
diseases as cardiovascular disease due to increased oxidation of lipoproteins and proaggregate 
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compounds (Simopoulos, 2002; 2006). An imbalance of n-6:n-3 also has been shown to be 
involved in the decline of the intestinal barrier function in gastrointestinal diseases such as IBD. 
Usami et al. (2003) reported independent incubation of 10 to 100 µmol of eicosapentaenoic acid 
(EPA), an n-3 fatty acid, decreased (p<0.01) TEER (0.75 vs. 0.95 of controls) and increased 
(p<0.05) paracellular transport in Caco-2 cell monolayers (2% permeability to fluorescein 
sulfonic acid [FS] vs. 1.3% in controls). Similarly, γ-linolenic acid (n-6) also was reported to 
decrease (p<0.001) Caco-2 cell monolayer paracellular permeability in a dose-dependent manner 
(8% FS permeability vs. 1% FS permeability in controls) and decrease (p<0.001) TEER (0.5% 
compared to 1% in controls) (Usami et al., 2003). This evidence shows the independent actions 
of n-3 and n-6 on paracellular permeability. In contrast, T84 human intestinal epithelial cells and 
a pancreatic lipase, used to facilitate deterioration of the intestinal barrier, incubated with a fat 
blend of n-6 (13.05 w%) and n-3 (1.87 w%) at 100 µM concentration was reported to have 
higher (p<0.001) TER and lower (p<0.001) IL-4 secretion compared to controls incubated with 
the pancreatic lipase only (Willemsen et al., 2008). This report suggests the association of n-6 
and n-3 together can reduce intestinal barrier damage and inflammation.  
Recent evidence also has shown an influence of high-fat diets on intestinal microbial 
communities, which may lead to increased systemic LPS and inflammation in obese models. 
Diet-induced obese-prone (DIO-P) rats fed a high-fat diet have been shown to have altered 
intestinal bacterial populations when compared to DIO-P rats fed a low-fat diet and diet-induced 
obese-resistent (DIO-R) rats fed a high-fat diet. For instance, cecal Bacteroidales and 
Clostridiales were increased (p<0.01) in DIO-P and DIO-R rats fed a high-fat diet (31% and 
23% of total bacteria, respectively) compared to DIO-P and DIO-R rats fed a low-fat diet (26% 
and 11% of total bacteria, respectively) (Barbier de La Serre et al., 2010). These findings were 
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accompanied by elevated (p<0.05) plasma LPS (10 EU/ml) in DIO-P rodents fed a high-fat diet 
compared to lean-fed and DIO-R rodents fed a high-fat diet (0.5 EU/ml) (Barbier de La Serre et 
al., 2010). In healthy male subjects, Erridge et al. (2007) reported that a high-fat diet increased 
(p=0.05) plasma endotoxins, from 8.2 pg/ml (baseline, before meal) to 12.2 pg/ml (after high-fat 
meal). Furthermore, an in vitro challenge of 1000 pg/ml LPS to human aortic endothelial cells 
was reported to elevate (p<0.05) IL-8 and TNF-α 3-fold compared to cells which received 0 
pg/ml LPS. These data indicate an association between high-fat diet-induced plasma endotoxin 
increases and inflammatory response (Erridge et al., 2007).  
Although various changes in dietary intake and intestinal bacteria may lead to increased 
permeability, the transition to disease ultimately involves proinflammatory cytokine release and 
deterioration of TJ architecture. The association between cytotoxicity and TJ dysfunction has 
been demonstrated by several research groups. Adams et al. (1993) demonstrated that T84 
human colonic cell lines incubated with IFN-γ in a dose-dependent manner (0, 10, 100, and 1000 
U/ml), decreased (p<0.05) monolayer relative resistance from 1.3 (0 U/ml IFN-γ) to less than 0.6 
(1000 U/ml IFN-γ) within 72 h of exposure. Ma et al. (2004) incubated Caco-2 cell monolayers 
with TNF-α and reported a decrease (p<0.01) in epithelial resistance (< 350 Ω*cm2) in those 
cells compared to controls without TNF-α (550 Ω*cm2). Peng et al. (2009) evaluated Caco-2 cell 
monolayers undergoing calcium switch procedures via removal and introduction of calcium into 
the cell culture medium to understand the mechanism of proinflammatory markers. Calcium is an 
essential mineral to the maintenance of the TJ; therefore, its removal from the medium led to the 
redistribution of TJ proteins, ZO-1 and occludin, from the apical-lateral membrane to the 
cytoplasm, which to increased cell monolayer permeability (Peng et al., 2009). These data 
concluded that immediate disruption to the TJ was due to the translocation of TJ adhesions to the 
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cytoplasm. Youakim and Ahdieh (1999) and Bruewer et al. (2003) reported that IFN-γ and TNF-
α decreased epithelial barrier TJ proteins by reducing protein expression and localization to the 
apical-lateral membrane, further clarifying the mechanism of action involved in the increased 
permeability of the epithelial layer. The mechanistic action of TNF-α on permeability is thought 
to function through the activation of the NF-κB signal transduction pathway, further leading to 
reorganization of TJ proteins and altered epithelial resistance due to cytokine-induced 
deterioration (Youakim and Ahdieh, 1999; Bruewer et al., 2003; Barbier de La Serre et al., 
2010). Indeed, through pharmacological inhibition of NF-κB, investigators have discovered a 
reduction in intestinal barrier permeability and increased TJ stability. Based on these findings, it 
is evident that long-term exposure of multiple proinflammatory cytokines can cause dysfunction 
of the epithelial barrier through TJ remodeling (Ammori et al., 1999; Zhang et al., 2010).  
Intestinal barrier dysfunction in obesity  
Researchers have found several sources of the proinflammatory markers produced in 
obesity, including both adipose and intestinal tissues. This inflammation further contributes to 
the metabolic dysfunction and disruption of the intestinal barrier. Not only does the metabolic 
dysfunction of hyperplastic adipocytes include insulin resistance, but also enlarged adipocytes 
have been implicated in being the predominant source of inflammation in obese individuals 
(Maury and Brichard, 2010). Ye et al. (2007) reported a 70% reduction (p<0.001) of the pO2 in 
the epidiymal fat pads of ob/ob (leptin-deficient) mice compared to lean controls. This difference 
in pO2 indicates the presence of hypoxia in the adipose tissue of these obese mice (Ye et al., 
2007). Furthermore, due to apoptosis and necrosis of adipocytes, secretion of proinflammatory 
cytokines, such as TNF-α and IL-6, from the adipose tissue was higher (p<0.001, p<0.05 
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respectively) in the ob/ob mice (10- and 5-fold, respectively) compared to lean controls (1- and 
1-fold, respectively) (Ye et al., 2007). 
Hypertropic adipocytes also secrete chemokines that recruit macrophages to eradicate 
cellular fragments after adipocyte apoptosis (Virtue and Vidal-Puig, 2010). Weisberg et al. 
(2003) identified macrophages by immunohistochemical staining for the antigen F4/80, which is 
an indicator of mature macrophages, within adipose tissue of lean and obese mice. The clustering 
of macrophages in the adipose tissue of the lean mouse model was minor and scattered 
throughout the tissue (Weisberg et al., 2003). Alternatively, macrophages in obese rodents were 
repeatedly found amassed in a crown-like structure around necrotic adipocytes.  
The diverse community of intestinal bacteria within the human gut has been known for 
many years to possess metabolic capabilities not present in the host. The bacterial microbiome is 
an additional ‘organ’ capable of metabolic functions, which are vital to the host. Due to high- 
throughput sequencing techniques, the global characterization and study of gut microbes has 
been identified. Saccharolytic activity by intestinal bacteria can yield fermentative end-products 
[e.g., short-chain fatty acids (SCFA)] that can be beneficial to the host that would have been 
otherwise lost to fecal excretion. However, in understanding the metabolic capabilities of 
intestinal bacteria, Backhed et al. (2004) reported that germ-free mice had increased (p<0.01) 
total body fat (57%) and epididymal fat weight (61%) after conventionalization (inoculation of 
unfractionated microbiota from ceca of control mice). This information demonstrates the 
importance of intestinal bacteria in energy harvest and the deposit of fat in subcutaneous stores.  
Researchers have tried to identify the potential role intestinal bacteria have in the 
metabolic dysfunction of obesity. Creely et al. (2006) reported metabolic endotoxemia to be 
greater (p<0.0001) in type 2 diabetes mellitus patients (5.5 log EU/ml) compared to non-diabetic 
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patients (3.1 log EU/ml). More specifically, endotoxin levels were noted to be higher (p=0.0031) 
in type 2 diabetic individuals with a BMI greater than 30; TNF-α serum levels were also 2.5 
times higher (p=0.00685) in these patients compared to non-diabetic controls with a BMI less 
than 30 (Creely et al., 2006). Researchers have debated whether the intestine of obese individuals 
contains variations in intestinal microbiota, with initial studies focused on the Bacteroidetes and 
Firmicutes phyla. Ley et al. (2005) reported a 50% decrease (p<0.05) in Bacteriodetes in ob/ob 
mice and an equal increase (p<0.05) in Firmicutes compared to lean controls. To understand if 
intestinal bacteria were changing due to the diet or the obese state, Ley et al. (2006) evaluated 
fecal samples of 12 obese human subjects on a fat-restricted or carbohydrate-restricted diet for 1 
yr. Before nutritional intervention, feces of obese subjects contained more (p=0.002) Firmicutes 
(90% of total rRNA gene sequences) and fewer (p<0.001) Bacteroidetes (< 5% of total rRNA 
gene sequences) compared to lean controls. As the subjects decreased in body weight, 
Bacteroidetes (70% of total rRNA gene sequences) increased (p<0.001) and Firmicutes (25% of 
total rRNA gene sequences) decreased (p=0.002); these findings were independent of diet 
composition (Ley et al., 2006). Strong correlations (r
2 
= 0.5 - 0.8) were noted between weight 
reduction and increased (p<0.05) Bacteriodetes. These data may indicate an alternation of 
intestinal bacteria based on weight (obese state) that is irrespective of diet type. Zhang et al. 
(2009) also reported evidence in support of microbiota change in an obese model. Fecal 
Prevotellaceae (phylum Bacteroidetes) were higher (p=0.040) in morbidly obese (BMI > 35) 
individuals (5% of total rRNA gene sequences) compared to normal weight controls (0% of total 
rRNA gene sequences) (Zhang et al., 2009). 
Current evidence suggests a connection between changing microbial communities in the 
obese and increased intestinal permeability and risk of endotoxemia. Barbier de La Serre et al. 
17 
 
(2010) reported a decrease in total bacterial 16S rRNA gene copies per gram wet weight in DIO-
P (3.5 x 10
7
) rats compared to DIO-R rats (5.0 x 10
7
). Enterobacteriales populations were > 2 
fold higher (p<0.05) in DIO-P compared to DIO-R rats independent of diet composition. In 
addition, plasma LPS concentrations were 9 times greater in the DIO-P mice fed a high-fat, 
compared to DIO-P and DIO-R rats on a high-fat diet and low-fat fed Sprague-Dawley rat 
controls (Barbier de La Serre et al., 2010). DIO-P rats also had greater (p<0.001) intestinal 
permeability (> 1 ug/ml dextran) compared to DIO-R rats (< 0.5 ug/ml). Intestinal permeability 
was attributed to translocation of the TJ protein, occludin, from the ileal TJ to the cytoplasm of 
the enterocytes. DIO-P rats contained greater (p<0.001) occludin proteins (15%; measured as the 
percentage of positive pixels in confocal images after immunochemical staining of designated 
tissue) in the ileal cytoplasm compared to DIO-R (5%). Collectively, this evidence suggests a 
strong relationship between a change in cecal intestinal bacteria, increased intestinal 
permeability, and endotoxemia. To assess whether high-fat diets increase LPS translocation to 
systemic circulation, Cani et al. (2007) gavaged C57BL/6 mice with LPS-oil or LPS-water 
mixtures. The oil resulted in higher LPS (p<0.05) absorption (4 EU/ml) compared to in LPS-
water controls (-2 EU/ml plasma LPS) within 30 min of treatment. In support of this work, Brun 
et al. (2007) reported that ob/ob and db/db (leptin-receptor deficient) obese mice had decreased 
(p<0.05) TER (25 Ω*cm2 and 32 Ω*cm2, respectively) compared to the wild-type control mice 
(44 Ω*cm2). These findings were associated with elevated (p<0.05) serum IL-6 (3 ng/ml, 7.5 
ng/ml, 2 ng/ml in ob/ob, db/db and control, respectively), IFN-γ (6.5 ng/ml, 31.5 ng/ml, and 6.5 
ng/ml, respectively) and TNF-α (60 ng/ml, 60.5 ng/ml, and 31.5 ng/ml, respectively). 
Furthermore, serum endotoxin concentrations were 3 times greater (p<0.02) in db/db mice 
compared to controls (Brun et al., 2007). These findings were attributed to TJ reorganization of 
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occludin and ZO-1 in the ileum. The authors concluded that ob/ob and db/db intestinal 
permeability and subsequent anomalies were attributed to the obese phenotype of these rodents 
rather than the lack of leptin function. These studies demonstrate an inflammatory state in obese 
models, possibly due to intestinal bacteria changes and endotoxemia.  
Benefits of intestinal bacteria and fructan-based prebiotics 
The bacterial ecosystem of the human gut contains over 500 microbial species in a 
quantity 10 times greater than the number of eukaryotic cells that make up the human body 
(Guarner and Malagelada, 2003). The colon contains the highest concentrations of bacterial cells, 
ranging from 10
11
 to 10
12
 bacterial cells/g of intraluminal contents (Gibson and Roberfroid, 
1995). Intestinal bacteria share a symbiotic relationship with humans, providing benefits such as 
salvaging energy from undigested carbohydrates, inhibition of pathogen colonization within the 
host gut, biosynthesis of vitamins, and by decreasing blood ammonia concentrations (Gibson and 
Roberfroid, 1995). Gnotobiotic rodents have been used recently to demonstrate metabolic 
functions of intestinal bacteria. Reikvam et al. (2011) depleted intestinal microbiota in 
conventional mice to understand the biological role of intestinal bacteria. In that study, mice 
were gavaged with amphotericin-B every 12 h for 3 d, followed by supplementation of 1 g/L of 
ampicillin into their drinking water and an antibiotic mixture of vancomycin, neomycin, 
metronidazol, and amphotericin-B every 12 h for 17 d (Reikvam et al., 2011). This treatment 
resulted in < 1 bacterial cfu/mg of feces, which was associated with hypoplastic Peyer’s patches 
and spleen, hyperplastic ceca, and reduced epithelial proliferation in the mice (Reikvam et al., 
2011). In addition to the effects of intestinal microbiota on gastrointestinal health and 
development, previous studies have found that the absence of intestinal bacteria also has effects 
on all organ systems and metabolic functions in the host. For instance, smaller liver, reduced 
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total blood volume and cardiac output, thinner alveolar and capsule wall in the lungs, and 
decreased iodine uptake by the thyroid gland were noted (Smith et al., 2007). In addition, 
intestinal morphology and immune function are altered. Studies have shown that germ-free 
models have cecal walls and mucosa that are thinner, decreased intestinal IgA, and increased 
susceptibility to pathogenic bacteria, such as Shigella flexneri and Listeria (Smith et al., 2007).  
Traditionally, bifidobacteria and lactobacilli were thought to be among the predominant 
beneficial bacteria within the human gut and have the greatest potential in metabolic capabilities 
of the host upon stimulation (Gibson and Roberfroid, 1995; Zhu et al., 2010). A large body of 
research has demonstrated the benefits of indigestible carbohydrates known as prebiotics, to 
selectively stimulate the growth and activity of commensal bacteria that in turn lead to health 
benefits in the host. As a probiotic bolus, Lactobacillus has been found to alleviate endotoxemia 
and reduce the pathology of alcoholic liver injury in Wistars rats consuming a corn oil and 
alcohol treatment (Nanji et al., 1994). Langlands et al. (2004) reported that the supplementation 
of 7.5 g of oligofructose and 7.5 g of inulin (total 15 g/d) tended to increase (p=0.059) 
bifidobacteria in the proximal colon of mucosal biopsies of healthy adults (6.3 CFU/g mucosa) 
compared to controls (5.3 CFU/g mucosa). Similarly, distal colon bifidobacteria of oligofructose-
and inulin-supplemented participants were greater (6.4 CFU/g mucosa, p<0.05) than those 
without prebiotic supplementation (5.2 CFU/g mucosa) (Langlands et al., 2004). Increased 
colonization of bifidobacteria has been associated with a reduction in pathogenic microflora, 
strengthened intestinal immune function via increased intestinal IgA plasmacytes, and reduced 
colon carcinogenesis and risk of bowel diseases (Mitsuoka, 1990; Grizard and Barthomeuf, 
1999). 
20 
 
 Cani et al. (2007) reported that Bifidobacterium spp. were lower (p<0.05) in the ceca of 
ob/ob mice fed a high-fat diet (less than 7.5 log bacterial cells/g cecal contents) compared to 
ob/ob mice fed a control diet (greater than 8.5 log bacterial cells/g cecal contents). In that study, 
plasma LPS was negatively correlated (r = ―0.41, p=0.025) with cecal bifidobacteria, suggesting 
a protective role offered by bifidobacteria against endotoxemia (Cani et al., 2007). Furthermore, 
Cani et al. (2009) reported a reduction (p<0.05) in plasma TNF-α levels of ob/ob mice (50 
pg/ml) fed a diet containing 10% oligofructose compared to ob/ob controls (200 pg/ml) fed a 
standard chow diet.  
While many dietary ingredients may possess some degree of prebiotic activity, fructans 
have been the most heavily studied and shown to promote health by promoting a “healthier” 
colonic microbiota. Fructans are primarily composed of β-(2 → 1) fructosyl-fructose linkages 
and are naturally found in chicory root, Jerusalem artichokes, onions, bananas, and wheat 
products (Roberfroid, 2005). The nomenclature of fructans is largely based on chain length. 
Inulin has the highest degree of polymerization (DP), which is between 10 and 60. Oligofructose 
is a partially hydrolyzed product of long-chained inulin and contains a DP less than 10 
(Roberfroid et al., 1998; Hernot et al., 2009). Short-chain fructooligosaccharides (scFOS) have 
an average DP of 3 – 6 and are most often synthesized from sucrose (Roberfroid et al., 2010). 
Depending on chain length, fructans are capable of exerting beneficial effects on the host 
through selective increase of beneficial microflora in different regions of the gut, ranging from 
the distal ileum to the distal colon.  
Fermentative by-products produced by intestinal microbiota are dependent upon the 
substrate fermented but, in general, end-products include hydrogen and carbon dioxide gases, 
ammonia, phenols, indoles, amines, SCFA, and other organic acids (Macfarlane, 1991). The 
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principal energy source derived from fermentation that is available to the host is in the form of 
SCFA, mainly acetate, propionate, and butyrate (Macfarlane and Macfarlane, 2003). Through the 
salvaging of this energy from dietary fibers, SCFA comprise 5-15% of human’s total caloric 
requirements (Hamer et al., 2008). Large intestinal contents of sudden death victims have been 
reported to contain concentrations of acetate: propionate: butyrate at 57:22:21 mmol/kg 
(Macfarlane and Macfarlane, 2003). However, because substrate availability and fermentative 
capacity is highest in the proximal colon, these concentrations declined from the proximal to 
distal colon. Acetate and propionate have roles in lipid and cholesterol synthesis as well as 
gluconeogenesis, whereas butyrate serves as the primary energy source for colonocytes. In 
addition, butyrate also has been shown to enhance colonic barrier defenses. Colonic mucosal 
scrapings obtained from colon cancer patients undergoing colectomy, followed by incubation 
with 0.1 mM of sodium butyrate, had increased (p<0.001; 80% more) mucin synthesis than 
controls incubated without sodium butyrate (Finnie et al., 1995). Paracellular transport in rat 
distal colonic epithelium also was altered upon exposure to 2 mmol/L of butyrate for 72 hr; 
transepithelial resistance was 83% higher (p<0.05) in butyrate-exposed epithelium compared to 
non-butyrate exposed controls (Mariadason et al., 1997).  
Intestinal bacteria are a metabolic powerhouse, which upon stimulation can increase 
intestinal health. Fructan treatments have successfully captured the metabolic capabilities of 
intestinal bacteria and have shown extended benefits beyond providing vitamins, increased 
immunity against pathogens, and production of SCFA, but have displayed capabilities of 
increasing epithelial cell proliferation, reducing intestinal inflammation and restoring intestinal 
barrier function in obese models. Fructan prebiotics are capable of supporting a healthy intestinal 
microbial community, which has shown to benefit a low-grade inflammatory obese model.  
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Thesis objective 
 
The general objective of this research was to identify mechanisms by which the integrity 
of the intestinal architecture and barrier are improved via supplementation of prebiotics with 
varying fermentation characteristics in an obese mouse model. Our main focus was on 
improvements of intestinal barrier function within this model. Therefore, we hypothesized that 
supplementation of prebiotics would lead to improved intestinal barrier function and increased 
expression of SCFA transporters and receptors, TJ proteins, AMP-kinase, and mucin (MUC2) 
genes. Additionally, we postulated that scFOS, a short-chain fructan prebiotic, would be rapidly 
fermented and have a greater response in the ileum and cecum of the mouse model, whereas 
inulin, a long-chain fructan prebiotic, would result in moderate improvements throughout the 
entire colon.  
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Chapter 3 
Effects of fructan source and degree of polymerization on intestinal barrier function and 
histomorphology characteristics in obese C57BL/6 mice  
Abstract 
Obesity is linked to increased intestinal permeability that may contribute to low grade 
inflammation. Fructan prebiotics have been demonstrated to increase intestinal resistance and 
decrease systemic inflammation. The objective of this study was to test the effects of prebiotics 
on intestinal permeability, morphology, and gene expression in an obese mouse model. Obese, 
18-wk old, C57BL/6 mice were randomized to high-fat (45% of kcal) diets containing 5% 
cellulose, 10% cellulose, 10% short-chain fructooligosaccharides (scFOS) or 10% inulin and fed 
for 28 d. Distal ileum, cecum, and colon samples were collected for Ussing chamber, 
histomorphology, and qRT-PCR analyses. The effects of treatment were tested using the Mixed 
Models procedure of SAS. Among treatments, mice fed scFOS and inulin had greater (p<0.05) 
intestinal transmural resistance compared to mice fed 5% cellulose. MCT-1 expression was 
greater (p<0.05) in the distal colon of mice fed 10% cellulose compared to 10% inulin. ZO-1 
expression was lower (p<0.05) in mice fed inulin compared to other treatments. Occludin mRNA 
abundance was lowest (p<0.05) in fructan sources compared to cellulose. When comparing 5% 
vs. 10% cellulose treatments using contrasts, 10% cellulose led to greater (p<0.05) intestinal 
crypt depth in all intestinal regions, except the distal colon.  Mice fed 5% vs. 10% cellulose, 
however, had greater (p<0.05) ileal villus height: crypt depth ratio, ileal MUC2 mRNA 
abundance, proximal colon AMPK mRNA abundance, and occludin mRNA abundance in the 
proximal and distal colon regions. When comparing fructan vs. cellulose treatments using 
contrasts, fructans resulted in a greater (p<0.05) transmural resistance and crypt depth when all 
intestinal regions were combined.  In contrast, fructan-fed mice had lower (p<0.05) mRNA 
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abundance of ZO-1 and occludin when all intestinal regions were combined (Table 3.5). Fructan 
consumption resulted in lower (p<0.05) ileal MUC2 and occludin mRNA abundance, cecal 
occludin mRNA abundance, proximal colon MCT-1, ZO-1, AMPK, and occludin mRNA 
abundance, and distal colon ZO-1, AMPK, and occludin mRNA abundance.  Cecal AMPK 
mRNA abundance was greater (p<0.05) in fructan-fed compared to cellulose-fed mice.  Pearson 
coefficient correlations indicated correlations between MCT-1 and distal colon ZO-1 (r = 0.77, 
p<0.05) and occludin mRNA abundance (r = 0.66, p<0.05). AMPK correlated with ZO-1 mRNA 
abundance (r = > 0.60, p<0.05) in all regions of the intestinal tissue of C57BL/6 mice. Lastly, 
ZO-1 mRNA abundance correlated with distal colon epithelial resistance (r = 0.51, p<0.05). 
Collectively, these data may suggest mechanisms by which equivalent quantities of fructan 
prebiotics and non-fermentable fibers affect intestinal barrier function.  
Introduction 
The intestinal barrier is essential in protecting the host from ingested pathogens and 
toxins and commensal intestinal bacteria. The main cause of increased intestinal permeability has 
been found to be overt inflammation, which is observed in disorders such as ulcerative colitis 
and Crohn’s disease, potentially causing sepsis (Hollander et al., 1986; Gardiner et al., 1995; 
Laukoetter et al., 2008; Huber et al., 2010). Intestinal barrier function is not only important in 
maintaining gastrointestinal health, but also appears to apply to obesity because of recent 
findings of increased intestinal permeability in obese mice. Brun et al. (2006) reported decreased 
(p<0.05; 55% lower) intestinal epithelial resistance in ob/ob mice than wild-type controls. That 
study also reported reduced occludin and ZO-1 tight junction protein abundance in the ileum. 
Barbier de La Serre et al. (2010) also reported increased intestinal permeability and decreased 
occludin at the tight junction in diet-induced obesity-prone rats. This evidence is alarming, yet 
few interventions have been reported effective in treating this decline in gut health.  
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Prebiotics may have positive effects in decreasing intestinal permeability, yet there is 
little evidence showing associations between prebiotics and intestinal barrier function in an obese 
model. Cani et al. (2009) showed that supplementation of oligofructose, a fructan prebiotic, 
increased intestinal resistance and ZO-1 protein abundance in obese C57BL/6 mice fed a high-fat 
(70% of kcal) diet. Given the extreme diets fed in that study, however, further research is 
required using more realistic diets and to identify potential mechanisms by which prebiotics may 
be improving barrier function.  Therefore, with this evidence in mind, the primary objective of 
this study was to evaluate the effects of fructan prebiotics of different degree of polymerization 
(DP) on intestinal barrier function in an obese mouse model.   
Materials and Methods 
All animal care procedures were approved by the University of Illinois Institutional Animal Care 
and Use Committee prior to animal experimentation. 
Animals and diets 
Twenty-four 18-wk old C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME) were used 
in a completely randomized design.  Mice were assigned a pelleted American Institute of 
Nutrition-1993 growth (AIN-93G)-based diet containing 45% kcal from fat and 5% cellulose 
during a 2-wk acclimation period (Table 3.1 and Table 3.2). Mice then were randomized to four 
pelleted AIN-93G-based diets containing 45% kcal from fat containing either non-fermentable 
dietary fiber or fructan-derived prebiotics. Dietary treatments included: 1) 5% cellulose; 2) 10% 
cellulose; 3) 10% short-chain fructooligosaccharides (scFOS); and 4) 10% inulin, and were fed 
ad libitum for 4 wk. The mice were individually housed in shoe-box cages in the Institute for 
Genomic Biology Animal Facility at the University of Illinois. Environmental conditions were 
controlled with a 12-h light-dark cycle with ad libitum feeding, free access to water, weekly 
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health inspections, and body weight measurements. Visible offered, but refused treatments were 
recorded daily.  
Blood and tissue collection  
Upon completion of the 4-wk intervention, mice were fasted for 6 h, followed by CO2 
asphyxiation. Blood was collected via cardiac puncture. Intestinal sections were collected from 
the ileum, cecum, proximal colon, and distal colon for intestinal morphology, quantitative 
reverse transcriptase-polymerase chain reaction (qRT-PCR), and intestinal permeability 
measurements. All intestinal sections were rinsed in modified Kreb’s buffer solution and placed 
in formalin for histomorphological analysis or modified Kreb’s buffer solution for 
electrophysical analysis of intestinal resistance. A third portion of each tissue was flash frozen in 
liquid nitrogen and stored at -80°C until further analysis.   
Intestinal permeability measurement using modified Ussing chambers 
Intestinal samples were resected, cut longitudinally, and mounted  into modified Ussing 
chambers (Physiological Instruments, Inc., San Diego, CA) exposing 0.031 cm
2
 of the mucosal 
and serosal sides to 8 mL of oxygenated  (95% O2 and 5% CO2) modified Krebs buffer solution 
maintained at 37°C by use of a circulation water bath (IsoTemp 2006S, Fisher Scientific, Itasca, 
IL). After allowing 10-20 min to reach equilibrium, transmural resistance (Ohm x cm
2
) was 
measured. The modified Ussing chambers were connected to dual channel voltage/current 
clamps (VCC MC2, Physiological Instruments) with a computer interface that allowed for real 
time data acquisition and analysis with Acquire and Analyze software (Physiological 
Instruments). 
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Intestinal histomorphology measurement  
Intestinal samples were fixed in formalin and embedded in paraffin and sectioned to 4 
m thickness using a microtome and stained with hematoxylin and eosin at the University of 
Illinois at Urbana-Champaign Veterinary Pathology Laboratory. Ileal villus height, ileal crypt 
depth, cecal crypt depth, and colon crypt depth measurements were performed on 15 well-
oriented, intact villi and crypts using Axiovision AC software and an AxioCam MRc5 (Carl 
Zeiss, Obercochen, Germany).  
RNA extraction and analyses  
Total cellular RNA was isolated from tissue samples using the RNeasy Kit (Qiagen, 
Valencia, CA).  RNA concentration was determined using a ND-1000 spectrophotometer 
(Nanodrop Technologies, Wilmington, DE).  RNA integrity was confirmed by gel 
electrophoresis prior to qRT-PCR analyses. TaqMan Gene Expression Assays primer-probe sets 
(Applied Biosystems, Foster City, CA) were used for each gene of interest [monocarboxylic 
transporter-1 (MCT-1), monocarboxylic transporter-4 (MCT-4), solute carrier family 5, member 
8 (SLC5A8), solute carrier family 5, member 12 (SLC5A12), G-protein coupled receptor-43 
(GPR43), AMP-kinase (AMPK), mucin 2 (MUC2), zonula occluden-1 (ZO-1), occludin, and 
taste receptor type 2-38 (T2R38, bitter taste receptor)]. Real-time two-step RT-PCR was 
performed using the Applied Biosystems 7900HT Real-Time PCR System (Applied 
Biosystems).  Each gene was tested in triplicate, using eukaryotic 18S rRNA as a control in 
parallel with genes of interest.  Data were normalized to 18S rRNA and expressed as a ratio to 
the 18S rRNA signal.  
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Chemical analyses  
Diet samples were analyzed for dry matter and organic matter according to AOAC 
(1984). Crude protein was determined using a Leco Nitrogen/Protein Determinator (model FP-
2000, Leco Corporation, St. Joseph, MI) (AOAC, 1995). Fat concentrations were measured by 
acid hydrolysis (AACC, 1983) followed by ether extraction (Budde, 1952). Gross energy was 
measured by the use of a bomb calorimeter (Model 1261, Parr Instruments, Moline, IL). Total 
dietary fiber (TDF) concentrations were determined using methods described by Prosky et al. 
(1985). Calculated TDF was based on purities provided by Orafti (Tienen, Belgium) for inulin 
(Raftiline HP; 95.5%), Research Diets (New Brunswick, NJ) for cellulose (Solka-Floc; 99%), 
and GTC Nutrition (Golden, CO) for scFOS (NutraFlora; 95%).  
Statistical analyses  
 Histomorphology, transmural resistance, and PCR data were analyzed using the Mixed 
Models procedure of SAS ® (SAS Institue, Cary, NC). Data were transformed to obtain 
normality (using the log and square root transformations, respectively). Statistical analysis and 
differences were determined utilizing the transformed data; however, observed means are 
presented in the tables, figures, and text. The fixed effect of diet across all regions, and within 
each region was tested. Sampling day was considered a random effect. Differences were 
determined using a Fisher-protected LSD with a Tukey adjustment to control for experiment-
wise error. A probability of P ≤ 0.05 was accepted as statistically significant.  Intestinal 
morphology, intestinal resistance, and gene expression data sets were analyzed for Pearson 
correlation coefficients by using the PROC CORR procedure of SAS® (SAS Institue, Cary, NC).  
A probability of P ≤ 0.05 was accepted as statistically significant.   
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Results 
Mean daily food intake and body weight 
 Mean daily food intake (g/d) during the 4-wk treatment period was greater (p<0.05) in 
mice fed 10% cellulose compared to those fed 5% cellulose, 10% scFOS or 10% inulin (Figure 
3.1).  
 Body weights at baseline (39.5 ± 0.9, 39.4 ± 0.9, 38.9 ± 0.9, and 37.8 g ± 0.9 for 5% 
cellulose, 10% cellulose, 10% scFOS, and 10% inulin, respectively) were lower (P<0.0001) than 
those after 4 wk (42.0 ± 0.5, 43.6 ± 0.5, 42.1 ± 0.5, and 41.9 g ± 0.5 for 5% cellulose, 10% 
cellulose, 10% scFOS, and 10% inulin, respectively) for all treatments (Figure 3.2). 10% 
cellulose-fed mice were heavier (p<0.01) at 24 wk compared to remaining treatments. 
Histomorphology 
Intestinal histomorphological effects of prebiotic supplementation were assessed by 
measuring ileal villus height and crypt depth and crypt depth of the cecum, proximal colon, and 
distal colon (Table 3.3 and Figure 3.3).  Mice fed scFOS had substantial improvements in 
intestinal architecture. Specifically, ileal villus height was greater (p<0.05) in mice fed scFOS 
compared to those fed 5% cellulose and ileal and cecal crypt depth was greater (p<0.05) in mice 
fed scFOS or inulin compared to those fed 5% and 10% cellulose. Inulin-fed mice had greater 
(p<0.05) proximal colon crypt depth compared to 10% scFOS- and 10% cellulose-fed mice. 
Lastly, mice fed 10% cellulose had increased (p<0.05) distal colon crypt depth compared to mice 
fed 10% scFOS. The villus height:crypt depth ratio was greater (p<0.05) in mice fed 5 or 10% 
cellulose compared to mice fed scFOS or inulin.  
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Intestinal transmural resistance 
Intestinal transmural resistance of the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice was evaluated by assessing the resistance in a Ussing chamber (Figures 3.4 and 
3.5). The main effect of diet among regions was not significant, however, mice supplemented 
with inulin and scFOS had greater (p<0.05) intestinal transmural resistance in the cecum and 
distal colon, respectively, compared to cellulose-fed mice.   
SCFA transporter and receptor mRNA abundance 
SCFA transporter and receptor mRNA abundance was assessed to determine the possible 
involvement of these genes in connection with intestinal permeability (Figure 3.6 – Figure 
3.11). The main effect of diet on SCFA transporters and receptor were not significant; however, 
MCT-1 mRNA abundance increased (p<0.05) in the distal colon of mice-fed 10% cellulose 
compared to inulin-fed mice. Yet, MCT-4 and GPR43 mRNA abundance was not significant in 
any region of murine intestine.  
MUC2 mRNA abundance 
In order to determine the involvement of other factors contributing to intestinal 
resistance, expression of MUC2 was assessed using  qPCR (Figure 3.12 & Figure 3.13). A 
significant increase (p<0.05) of MUC2 mRNA abundance was observed in the ileum of mice fed 
10% cellulose compared to fructan-treated mice. However, the main effect of diet among regions 
was not significant.  
AMPK, ZO-1, and occludin mRNA abundance  
 New evidence by Peng et al. (2009) demonstrated a connection between AMPK, which is 
an energy sensor of cellular activity (i.e. assesses the presence of ATP) and the tight junction 
proteins, ZO-1 and occludin. The main effect of diet on AMPK mRNA abundance was not 
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significant among treatments (Figure 3.14 – Figure 3.19). However, specific to the cecum, 10% 
scFOS-fed mice produced greater (p<0.05) AMPK mRNA abundance vs. 5% cellulose-fed mice. 
Inulin-fed mice had substantially lower (p<0.05) AMPK mRNA abundance in the distal colon 
compared to cellulose and scFOS-fed mice. Across all regions, ZO-1 mRNA abundance was 
significantly lower (p<0.05) in inulin-fed mice compared to cellulose and scFOS treatments. 
Inulin-fed mice also had lower (p<0.05) ZO-1 mRNA abundance in the distal colon versus 
cellulose and scFOS-fed mice. Among all regions, cellulose-fed mice had greater (p<0.05) 
occludin mRNA abundance than fructan-fed mice. Ileal, proximal colon, and distal colon 
occludin mRNA abundance was also lower (p<0.05) in inulin-fed mice compared to cellulose- 
and scFOS-fed mice. Cecal occludin, however, was lower (p<0.05) in 10% cellulose- and 10% 
scFOS-fed mice compared to those fed 5% cellulose.  
Contrasts of 5% cellulose vs. 10% cellulose treatments and cellulose vs. fructan treatments 
Contrast statements were used to determine any differences in resistance, mRNA 
abundance, and histomorphology characteristics between mice fed 5% cellulose and 10% 
cellulose (Table 3.4). Overall, 10% cellulose was found to increase (p<0.05) intestinal crypt 
depth in all regions, except the distal colon. Mice fed 5% cellulose, however, had greater 
(p<0.05) ileal villus height: crypt depth ratio, ileal MUC2 mRNA abundance, proximal colon 
AMPK mRNA abundance, and occludin mRNA abundance in the proximal and distal colon 
regions.  
  Contrast statements also were used to determine differences in mice fed fructans 
compared to those fed cellulose.  Fructan consumption led to greater (p<0.05) transmural 
resistance and crypt depth when all intestinal regions were combined.  In contrast, fructan-fed 
mice had lower (p<0.05) mRNA abundance of ZO-1 and occludin when all intestinal regions 
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were combined (Table 3.5). Fructan consumption resulted in lower (p<0.05) ileal MUC2 and 
occludin mRNA abundance, cecal occludin mRNA abundance, proximal colon MCT-1, ZO-1, 
AMPK, and occludin mRNA abundance, and distal colon ZO-1, AMPK, and occludin mRNA 
abundance.  Cecal AMPK mRNA abundance was greater (p<0.05) in fructan-fed compared to 
cellulose-fed mice.  
Correlations between intestinal histomorphology,  transmural resistance, and mRNA abundance 
 Many significant correlations (p<0.05) were observed between intestinal 
histomorphology, transmural resistance, and gene expression (Tables 3.6 and 3.7).  Ileal MUC2 
expression was negatively correlated with ileal villus height, but positively correlated with ileal 
transmural resistance.  Proximal colon AMPK expression was positively correlated with 
proximal colon crypt depth, while distal colon ZO-1 expression was positively correlated with 
distal colon transmural resistance.  AMPK expression was positively correlated with the 
expression of MCT-1 (distal colon), MCT-4 (distal colon), ZO-1 (all regions), and occludin 
(distal colon).  MCT-1 expression was positively correlated with the expression of ZO-1 (ileum, 
cecum, and distal colon) and occludin (distal colon), while MCT-4 expression was positively 
correlated with the expression of ZO-1 (cecum and distal colon).  Finally, occludin expression 
was positively correlated with ZO-1 expression (proximal and distal colon).   
Discussion 
The current study was pursued to understand the risk of obesity and associated 
comorbidites, such as low-grade inflammation, on increased intestinal barrier permeability. Over 
70% of Americans are overweight or obese due to poor dietary habits. Evidence is limited in 
showing low-grade inflammation and intestinal barrier permeability in human subjects, however, 
a pilot study performed by Brignardello et al. (2010) showed obese subjects (BMI 35.9, n=13) 
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had significantly higher C-reactive protein serum levels compared to normal weight controls 
(BMI 23.5, n=11). In addition, the obese group had higher gut permeability of mannitol (151 mg) 
compared to that of normal weight individuals (115 mg). These data were not significant, but 
showed the presence of intestinal barrier permeability within this small group of subjects and 
suggested a need for an intervention.  
Our study utilized C57BL/6 mice fed high-fat diets to simulate the obesogenic states of 
Americans. Furthermore, this model also presents with diabetes mellitus and cardiovascular 
disease, which are common co-morbidities associated with obesity; our model presented with 
low-grade inflammation (data not shown) and increased body weight upon high dietary fat 
intake, which epitomizes Western behavior and diet. Our study did not utilize control mice, 
however, normal growth data reported from Jackson Laboratory (Jackson Laboratory, Bar 
Harbor, ME) on the weight gain of C57BL/6 mice fed a 6% fat diet showed a steady incline in 
the weight (13.59 g at 4 wk to 29.97 g at 16 wk of age) at which the weight did not plateau. 
Therefore we were confident a low-fat diet (control group fed a lower fat diet) would produce a 
phenotype lower in weight than our mice fed a 45% fat diet.   
In humans, the bacterial count per gram wet weight of contents is greatest in the proximal 
colon due to high substrate availability, enabling the growth of diverse bacteria (Leser & 
Molbak, 2009).  Intestinal microbiota possess many fermentative enzymes not possessed by the 
host, and are capable of enzymatically breaking down ingested fermentable products and 
releasing substrates, such as short-chain fatty acids (SCFA), methane, phenols and lactate (Leser 
& Molbak, 2009; Roberfroid et al., 2010). Substrate availability continues to be high at cecal 
entry, and will undergo fermentation yielding approximately 75% more SCFA than distal colon 
fermentation (Macfarlane & Macfarlane, 2003). The fermentative capabilities of intestinal 
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bacteria from the distal ileum throughout the colon can effectively increase SCFA production, 
specifically butyrate, which is not only the preferred energy source for colonocytes, but increases 
epithelial cell proliferation, trophic growth of the intestinal mucosa, and increased transmural 
intestinal resistance (D’Argenio et al., 1996; Mariadason et al., 1997; Inan et al., 2000).  Several 
researchers have demonstrated the fermentability and prebiotic capabilities of dietary fibers, such 
as fructans (scFOS and inulin) and their ability to stimulate beneficial bacteria, such as 
Lactobacillus and Bifidobacteria, increase production of SCFA, and reduce intestinal 
permeability (Grizard & Barthomeuf, 1999; Bouhnik et al., 2007; Hernot et al., 2009). This 
evidence led to our investigation to study the effects of fructan prebiotics (scFOS and inulin) on 
intestinal resistance, histomorphology, and gene expression in the gastrointestinal tract. 
In examining the characteristics of these fructan prebiotics, Roberfroid et al. (1998) 
reported that in vitro fermentation of fructans with greater than 10 DP are fermented slower than 
lower DP fructans. Complementary to this work, Stewart et al. (2008) also found FOS containing 
DP <10 was quickly fermented in an in vitro model, whereas inulin (DP >20) was steadily 
fermented, which was depicted by time and SCFA production. Therefore, in light of this 
evidence, we hypothesized that scFOS would be rapidly fermented due to their low DP. 
Therefore, intestinal architecture and resistance would improve in the distal ileum and cecum, 
whereas inulin would be fermented at a slower rate and would have moderate effects on all 
regions of the hindgut.  
We demonstrated that fructan supplementation increased ileal and cecal crypt depth, the 
regions where most fermentative activity likely occurred.  Kleessen et al. (2003) reported that 
human-flora associated rats (germ-free rats inoculated with human microflora) fed a mixture of 
oligofructose and long-chain inulin had longer jejunal villi and greater crypt depth in the distal 
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colon. This information may reveal a potential benefit to a change in intestinal architecture upon 
prebiotic supplementation. To support this notion, Yason et al. (1987) and Hedemann et al. 
(2003) reported greater crypt depth as a response to increased epithelial cell turnover. This 
increased proliferation may subsequently lead to increased absorptive capabilities at the villus 
surface (Yason et al., 1987; Awad et al., 2011). In relation to these findings, Benjamin et al. 
(2000) reported that increased epithelial cell proliferation caused narrowing and reduced width of 
epithelial cells, which was associated with increased intestinal resistance. However, 10% 
cellulose-fed mice also had substantially deeper crypts in the distal colon compared to 10% 
scFOS-fed mice in this current study, which may suggest benefits of insoluble fiber in the 
hindgut. In contrast, soluble fibers may yield benefits to the proximal gut. Collectively, these 
data show a possible benefit to including a combination of insoluble and soluble fibers in the 
diet.   
Our data also demonstrated that scFOS and inulin increased transmural resistance 
compared to the 5% cellulose control group, with the highest resistance values occurring in the 
cecum and distal colon.  In agreement with our findings of improved intestinal resistance upon 
prebiotic supplementation, Cani et al. (2009) also reported increased intestinal resistance in 
obese mice supplemented with 10% oligofructose compared to standard chow fed mice. 
However, because the transmural resistance data of mice fed 10% cellulose were not 
significantly different from those fed the fructan treatments in the current study, this would 
suggest a concentration effect of specific dietary fibers rather than a solubility or fermentability 
effect. Yet, to better understand the mechanisms by which intestinal resistance was improved 
after prebiotic supplementation, other than mechanisms demonstrated by Benjamin et al. (2000), 
as mentioned previously, we assessed the expression (mRNA abundance) of many genes that 
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may be involved with increased fermentation, SCFA production, and consequent improvements 
in intestinal function.  We hypothesized that the expression of SCFA transporters, tight junction 
proteins, AMPK, and MUC2 would be positively correlated with intestinal barrier resistance. 
 In the present study, the main effect of diet had no significant effects on SCFA 
transporter and receptor mRNA abundance. This may suggest activation of these transporters, 
regardless of the type of fermentable substrate within these regions.  Given the previous 
literature on prebiotics and the response observed in histomorphology and resistance herein, 
however, other reasons for no change seem more likely.  It is possible that these transporters are 
not regulated at the mRNA level or are regulated by more than SCFA alone. SCFA transporters 
may also be involved in transport of other fermentation by-products, such as lactate. Lastly, the 
localization of these transporters could also play a role in SCFA or other by-product up-
regulation. Kirat & Kato (2000) used immunofluorescence images to show that the presence of 
MCT-1 was predominately concentrated at the basolateral crypt of the cecum, proximal colon, 
and distal colon of rumen models (Kirat & Kato, 2006). These authors further theorized that the 
entry of SCFA into the cell is caused by the diffusion of a protonated SCFA and transporters 
coupled with bicarbonate ions to transport deprotonated SCFA (Kirat & Kato, 2006).  
The protein adhesions of the tight junction complex, occludin and ZO-1, are very 
important in maintaining the resistance of the intestinal barrier. For example, Al-Sadi et al. 
(2011) reported that the selective knockout of occludin from Caco-2 monolayers and in mice 
caused increased transepithelial flux of macromolecules, such as mannitol, inulin, and dextran.  
Cani et al. (2009) reported increased intestinal ZO-1 expression in obese mice after oligofructose 
supplementation, which was also associated with decreased intestinal permeability. We observed 
a decrease in ZO-1 expression in the distal colon of inulin-fed mice, which was not expected due 
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to evidence showing steady fermentation of inulin and possible ability to reach the hindgut.  The 
results for occludin expression were not exactly as expected either.  Occludin acts as a bridge 
between adjacent epithelial cells. Therefore, increased expression of occludin may strengthen the 
bond between these cells while remaining firmly anchored to ZO-1 proteins located in the 
peripheral membrane of these cells (Groschwitz & Hogan, 2009).  We did not expect the 
expression of occludin to be decreased in the hindgut of mice fed inulin or scFOS, but that is 
what was observed in the proximal and distal colon of the current study.  We hypothesized that 
increased SCFA production would increase occludin expression.  It is possible, however, that 
other mechanisms were involved.  Stimulation may have been due to the nondigestible and bulky 
material provided in the form of cellulose, and the expansion of the colon that may have 
occurred, increasing the physical pressure on the tight junction complex within the colon.  
The expression of AMPK was assessed due to the growing evidence of its involvement in 
intestinal barrier maintenance. We found AMPK to be elevated in the cecum of 10% scFOS-fed 
mice, which was to be expected due to the high fermentative capacity. Peng et al. (2009) 
demonstrated the involvement of AMPK in regulating tight junction proteins and restoration of 
intestinal resistance. In that study, Caco-2 cell monolayers underwent calcium-switch procedures 
to cause limited relocation of occludin and ZO-1 to the tight junction complex. However, the 
addition of butyrate to the medium caused the majority of ZO-1 proteins to re-localize to the 
tight junction complex. Yet, when AMPK was inhibited in this medium, the addition of butyrate 
did not re-localize ZO-1 to the tight junction matrix and intestinal barrier function declined. This 
evidence may indicate that butyrate activates AMPK and, thus, accelerates the repair of damaged 
tight junction complexes.  Scharl et al. (2009) also reported the involvement of AMPK in 
intestinal permeability. T84 intestinal epithelial cells incubated for 6 h with IFN-γ increased 
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AMPK activation by 44% more than controls, which also was associated with decreased 
occludin expression. Our data showed a decline in occludin expression in prebiotic-
supplemented mice; however, this decline in expression occurred predominantly in the colon 
segments. This may also suggest the exhaustion of fermentative substrates and lack of dietary 
fiber, in general, before reaching the colon segments, limiting the expression of occludin to distal 
intestinal segments.  MCT-1 expression was positively correlated to the expression of AMPK, 
ZO-1, and occludin in the distal colon of our mouse model, which may suggest the involvement 
of these variables working together to benefit intestinal resistance. Proximal colon crypt depth 
was also correlated with AMPK, which may suggest that a change in intestinal architecture may 
positively influence intestinal resistance.  
Because the colon has a dense community of bacteria, the mucus layer has an important 
role in the protection against adhesive and invasive species of intestinal microbiota (Atuma et al., 
2001; Corazziari, 2009). It is well known that the mucus layer increases from the proximal to the 
distal regions of the gut (Kleessen et al., 2003; Corazziari, 2009). We proposed that increased 
mucin production may increase the thickness of the mucous layer in the gut and subsequently 
increase intestinal barrier function.  Overall, expression of MUC2 was greater in the proximal 
and distal colon, but was not statistically significant.  However, we observed a moderate 
correlation (R
2
 = 0.4) between ileal transmural resistance and ileal MUC2 expression, indicating 
a possible relationship between these variables, but actual depth of the intestinal mucus layer was 
not measured in this study.   
As stated, the importance of the intestinal barrier cannot be overlooked and, therefore, 
generates concern about the increased intestinal permeability noted in the metabolic 
dysfunctional state of obesity. Fructan prebiotics have shown promise in rectifying this problem. 
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Our study showed that intestinal transmural resistance improves with prebiotic supplementation, 
regardless of DP, in an obese mouse model. However, we also found higher concentrations of 
cellulose may have equivalent benefits throughout the gut or in specific regions, such as the 
colon. These data suggest that feeding a combination of both soluble and insoluble fibers may 
benefit the full length of the intestine, wherein, fructans have more immediate effects in the 
ileum and cecum, while cellulose-based fibers have beneficial effects in the distal regions of the 
colon.  
The nature of gene involvement in intestinal barrier maintenance is unclear, but our 
evidence identifies the regional expression of these markers and, therefore, contributes to the 
growing body of evidence regarding the involvement of prebiotic and cellulose fibers in 
intestinal barrier function and gut health. 
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Figure 3.1 Average daily food intake of C57BL/6 mice (n=6). Means lacking a common 
superscript letter differ (p<0.05).  
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Figure 3.2 Body weight of C57BL/6 mice (n=6) at 24-wk. Means lacking a common 
superscript letter differ (p<0.01).  
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Figure 3.3 Ileal villus height: crypt depth ratios in C57BL/6 mice (n=6). Means lacking a 
common superscript letter differ (p<0.05). 
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Figure 3.4 Transmural resistance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6). Means lacking a common superscript letter differ (p<0.05). 
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Figure 3.5 Main effect of diet on transmural resistance among regions in C57BL/6 mice 
(n=6). Means lacking a common superscript letter differ (p<0.05). 
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Figure 3.6 MCT-1 mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).  Means lacking a common superscript letter differ (p<0.05).  
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Figure 3.7 Main effect of diet on MCT-1 mRNA abundance among regions in C57BL/6 mice (n=6).  
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Figure 3.8 MCT-4 mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).    
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Figure 3.9 Main effect of diet on MCT-4 mRNA abundance among regions in C57BL/6 mice (n=6).    
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Figure 3.10 GPR43 mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).   
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Figure 3.11 Main effect of diet on GPR43 mRNA abundance among regions in C57BL/6 mice (n=6).   
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Figure 3.12 MUC2 mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).  Means lacking a common superscript letter differ (p<0.05).  
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Figure 3.13 Main effect of diet on MUC2 mRNA abundance among regions in C57BL/6 mice (n=6).    
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Figure 3.14 AMPK mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).  Means lacking a common superscript letter differ (p<0.05).  
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 Figure 3.15 Main effect of diet on AMPK mRNA abundance among regions in C57BL/6 mice 
(n=6).   
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Figure 3.16 ZO-1 mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).  Means lacking a common superscript letter differ (p<0.05).  
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Figure 3.17 Main effect of diet on ZO-1 mRNA abundance in C57BL/6 mice (n=6).  Means lacking 
a common superscript letter differ (p<0.05).  
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Figure 3.18 Occludin mRNA abundance in the ileum, cecum, proximal colon, and distal colon of 
C57BL/6 mice (n=6).  Means lacking a common superscript letter differ (p<0.05).  
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Figure 3.19 Main effect of diet on occludin mRNA abundance among regions in C57BL/6 mice 
(n=6).  Means lacking a common superscript letter differ (p<0.05).  
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Table 3.1 Ingredient composition of pelleted AIN-93G diets containing 45% kilocalories as fat and either non-fermentable 
dietary fiber or fructan prebiotics (g/kg) 
Ingredient 5% cellulose 10% cellulose 10% inulin 10% scFOS 
Casein, 80 mesh  233.1 220.2 220.2 220.2 
L-cystine     3.5 3.3 3.3 3.3 
Cornstarch   84.8                 80.2                 80.2                 80.2 
Maltodextrin 116.5 110.1 110.1 110.1 
Sucrose                    201.4               190.3               190.3               190.3 
Cellulose    58.3   110.1 0.0 0.0 
Inulin     0.0 0.0 110.1 0.0 
Fructooligosaccharides     0.0 0.0 0.0     110.1 
Soybean oil   29.1 27.5 27.5 27.5 
Lard                    206.8               195.5               195.5               195.5 
Mineral mix
1
                      52.4 52.4 52.4 52.4 
Vitamin mix
2
                      11.7 11.7 11.7 11.7 
Choline bitartrate                        2.3 2.3 2.3 2.3 
1 Mineral mix consists of: calcium carbonate anhydrous (357 g), potassium phosphate monobasic (196 g), potassium citrate, tripotassium monohydrate (70.78 g), sodium 
chloride (74 g), potassium sulfate (46.60 g), magnesium oxide (24 g), ferric citrate (6.06 g), zinc carbonate (1.65 g), sodium meta-silicate-9H2O (1.45 g), manganous 
carbonate (0.63 g), cupric carbonate (0.30 g), chromium potassium sulfate-12H2O (0.28 g), boric acid (81.5 mg), sodium fluoride (63.5 mg), nickel carbonate (31.8 mg), 
lithium chloride (17.4 mg), sodium selenate anhydrous (10.25 mg), potassium iodate (10 mg), ammonium paramolybdate-4H2O (7.95 mg), and ammonium vanadate (6.6 
mg).  
2Vitamin mix consists of:  nicotinic acid (3 g), calcium pantothenate (1.60 g), pyridoxine-HCl (0.70 g), thiamin-HCl (0.60 g), riboflavin (0.60 g), folic acid (0.20 g), biotin 
(0.02 g), vitamin B-12 (2.50 g), vitamin E (15 g), vitamin A (0.80 g), vitamin D3 (0.25 g) and vitamin K (0.08 g).  
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Table 3.2 Chemical composition of pelleted AIN-93G diets containing 45% kilocalories as fat and either non-fermentable 
dietary fiber or fructan prebiotics 
Item 5% cellulose 10% cellulose 10% inulin 10% scFOS 
DM, % 93.8 93.8 93.0 93.6 
OM, % 96.0 96.2 96.2 96.2 
Ash, % 4.1 3.9 3.8 3.9 
CP, % 25.6 20.6 20.9 21.1 
Acid hydrolyzed fat, %  25.2 24.1 23.8 22.3 
Total dietary fiber, %  6.5 11.3 1.8 0.8 
    TDF calculated, % 6.4 11.2 12.8 11.8 
Gross energy, kcal/g  5.6 5.4 5.4 4.8 
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Table 3.3 Villus height and crypt depth in the ileum, cecum, proximal colon, and distal colon of C57BL/6 mice (n=6)  
 5% cellulose 10% cellulose 10% scFOS 10% inulin 
 
Ileal villus height 201.0 ± 12.2
b
   210.9 ± 12.2
ab
   224.7 ± 12.2
a
     204.0 ± 12.2
ab
 
 
Ileal crypt depth 90.9 ± 2.7
c
  96.9 ± 2.7
b
 123.0 ± 2.7
a
  122.0 ± 2.7
a
 
 
Cecal crypt depth       109.3 ± 3.6
b
          110.6  ± 3.6
bc
         140.8  ± 3.6
a
 110.6  ± 3.6
a
 
 
Proximal colon crypt depth      139.8  ± 11.3
ab
          115.8  ± 11.3
c
  126.8  ± 11.3
b
  140.6  ± 11.3
a
 
 
Distal colon crypt depth       205.2 ± 7.7
a
           211.5 ± 7.7
a
  178.4 ± 7.7
b
  205.3 ± 7.7
a
 
Values represents lsmeans ± pooled SEM. LSmeans lacking a common superscript letter differ (p<0.05). 
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Table 3.4 Contrasts between 5% cellulose and 10% cellulose treatments 
 5% cellulose 10% cellulose Pooled SEM 
Villus : crypt ratio                       2.1 1.9 0.1 
All regions    
    Crypt depth                   135.7                   144.3 2.6 
    Occludin mRNA abundance                       1.2  0.9 0.1 
Ileum    
    Crypt depth                      96.9                  112.0 2.5 
    MUC2 mRNA abundance 0.7 0.4 0.1 
Cecum    
    Crypt depth                    110.6                   131.8 3.4 
Proximal colon    
    Crypt depth                    115.8                   135.7                  10.9 
    Occludin mRNA abundance                                                                                                    1.6 0.8 0.1 
    AMPK mRNA abundance                                                   1.5  1.2 0.2 
Distal colon    
    Crypt depth                    211.5                   196.3 7.2 
    Occludin mRNA abundance                       1.2  0.7 0.1 
All contrasts shown are significant (p<0.05). 
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Table 3.5 Contrasts between cellulose-containing treatments and fructan-containing treatments 
 Cellulose fibers Fructan fibers Pooled SEM 
Villus : crypt ratio 2.2  1.8 0.1 
All regions    
    Crypt depth                  135.3                   149.0 2.4 
    Transmural resistance                    60.4 74.4 4.9 
    ZO-1 mRNA abundance  1.4   1.2 0.1 
    Occludin mRNA abundance  1.2   0.8 0.1 
Ileum    
    Crypt depth 93.9                  122.5 2.5 
    MUC2 mRNA abundance  0.6  0.3 0.0 
    Occludin mRNA abundance  1.4  1.0 0.2 
Cecum    
    Crypt depth                   110.0                  143.0 3.2 
    Transmural Resistance  67.0 87.1                 11.5 
    AMPK mRNA abundance    1.3  1.8 0.2 
    Occludin mRNA abundance    0.9  0.8 0.0 
Proximal colon    
    Crypt depth                    127.8                  133.7                 10.8 
    MCT-1 mRNA abundance    0.8  0.5 0.1 
    ZO-1 mRNA abundance    1.3  1.0 0.1 
    AMPK mRNA abundance   1.4  1.1 0.1 
    Occludin mRNA abundance   1.4  0.7 0.1 
Distal colon    
   Crypt depth                    208.3                  191.9 7.0 
   Transmural Resistance                     37.7                    55.8 6.4 
   ZO-1 mRNA abundance    1.3  1.0 0.2 
   AMPK mRNA abundance    1.0  0.7 0.1 
   Occludin mRNA abundance    1.1  0.6 0.1 
All contrasts shown are significant (p<0.05). 
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Table 3.6 Correlations between intestinal histomorphology, transmural resistance, and mRNA abundance in C57BL/6 mice 
*p<0.05. 
 
 
 
 Ileal villus 
height 
Ileal 
crypt depth 
Ileal transmural 
resistance  
Cecal crypt 
depth 
Cecal 
transmural 
resistance  
MCT-1 (MCT-1 mRNA/18S rRNA)      
Ileum -0.2 0.2 0.4   
Cecum    0.4 0.2 
MUC2 (MUC2 mRNA/18S rRNA)      
Ileum -0.5* 0.2   0.4*   
Cecum    0.0 0.1 
Ocln (Occludin mRNA/18S rRNA)      
Ileum 0.1 0.2 0.4   
Cecum    0.1 0.2 
  Proximal colon 
crypt depth 
Proximal colon 
transmural 
resistance 
Distal colon 
crypt depth 
Distal colon 
transmural 
resistance 
MUC2 (MUC2 mRNA/18S rRNA)      
Proximal colon  0.3 0.1   
Distal colon    -0.3 -0.2 
AMPK (AMPK mRNA/18S rRNA)      
Proximal colon  0.5* 0.2   
Distal colon    0.3 0.4
 
ZO-1 (ZO-1 mRNA/18S rRNA)      
Proximal colon  0.5 -0.1   
Distal colon    0.0  0.6* 
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Table 3.7 Correlations between mRNA abundance in C57BL/6 mice 
 MCT-1 
(MCT-1 mRNA/18 
rRNA) 
Ileum, cecum, 
proximal and distal 
colon 
MCT-4 
(MCT-4 mRNA/18 
rRNA) 
Ileum, cecum, 
proximal and distal 
colon 
AMPK 
(AMPK mRNA/18 
rRNA) 
Ileum, cecum, 
proximal and distal 
colon 
ZO-1 
(ZO-1 mRNA/18 
rRNA) 
Ileum, cecum, 
proximal and 
distal colon 
AMPK (AMPK 
mRNA/18S rRNA) 
    
Ileum 0.4   0.2   
Cecum 0.3   0.3   
Proximal colon 0.4                  -0.2   
Distal colon   0.6*     0.6*   
ZO-1 (ZO-1 mRNA/18S 
rRNA) 
    
Ileum   0.6*   0.2 0.9*  
Cecum   0.5*     0.4* 0.6*  
Proximal colon 0.2                   0.1 0.7*  
Distal colon   0.8*     0.6* 0.8*  
Ocln (Occludin 
mRNA/18S rRNA) 
    
Ileum 0.0  -0.2                 0.1              0.3 
Cecum 0.1   0.3                   0.0             -0.3 
Proximal colon 0.1 - 0.3                 0.4  0.5* 
Distal colon   0.7*   0.3
 
0.7*  0.8* 
*p<0.05. 
 
